全文获取类型
收费全文 | 3926篇 |
免费 | 286篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 124篇 |
妇产科学 | 73篇 |
基础医学 | 578篇 |
口腔科学 | 70篇 |
临床医学 | 453篇 |
内科学 | 794篇 |
皮肤病学 | 116篇 |
神经病学 | 351篇 |
特种医学 | 115篇 |
外科学 | 363篇 |
综合类 | 19篇 |
一般理论 | 1篇 |
预防医学 | 388篇 |
眼科学 | 106篇 |
药学 | 243篇 |
中国医学 | 11篇 |
肿瘤学 | 406篇 |
出版年
2024年 | 7篇 |
2023年 | 41篇 |
2022年 | 90篇 |
2021年 | 140篇 |
2020年 | 84篇 |
2019年 | 134篇 |
2018年 | 114篇 |
2017年 | 95篇 |
2016年 | 109篇 |
2015年 | 108篇 |
2014年 | 146篇 |
2013年 | 213篇 |
2012年 | 305篇 |
2011年 | 312篇 |
2010年 | 156篇 |
2009年 | 143篇 |
2008年 | 261篇 |
2007年 | 215篇 |
2006年 | 242篇 |
2005年 | 252篇 |
2004年 | 190篇 |
2003年 | 190篇 |
2002年 | 187篇 |
2001年 | 36篇 |
2000年 | 20篇 |
1999年 | 40篇 |
1998年 | 38篇 |
1997年 | 31篇 |
1996年 | 31篇 |
1995年 | 27篇 |
1994年 | 17篇 |
1993年 | 10篇 |
1992年 | 15篇 |
1991年 | 7篇 |
1990年 | 6篇 |
1989年 | 8篇 |
1988年 | 13篇 |
1987年 | 9篇 |
1986年 | 9篇 |
1985年 | 9篇 |
1984年 | 12篇 |
1983年 | 8篇 |
1982年 | 11篇 |
1981年 | 16篇 |
1980年 | 15篇 |
1979年 | 10篇 |
1978年 | 7篇 |
1977年 | 7篇 |
1971年 | 6篇 |
1958年 | 5篇 |
排序方式: 共有4233条查询结果,搜索用时 0 毫秒
61.
Beatrice Orso PsyD Dario Arnaldi MD Nicola Girtler PsyD Andrea Brugnolo PsyD Elisa Doglione PsyD Pietro Mattioli MD Erica Biassoni MD Roberto Fancellu MD Federico Massa MD Matteo Bauckneht MD Silvia Chiola MD Silvia Morbelli MD Flavio Nobili MD Matteo Pardini MD 《Movement disorders》2021,36(10):2293-2302
62.
Francesco Manfredi Danilo Abbati Beatrice Claudia Cianciotti Lorena Stasi Alessia Potenza Eliana Ruggiero Zulma Magnani Erica Carnevale Matteo Doglio Maddalena Noviello Elena Tassi Chiara Balestrieri Silvia Buonanno Francesca Clemente Claudia De Lalla Maria Pia Protti Anna Mondino Giulia Casorati Paolo Dellabona Chiara Bonini 《European journal of immunology》2021,51(8):1992-2005
The phenotype of infused cells is a major determinant of Adoptive T-cell therapy (ACT) efficacy. Yet, the difficulty in deciphering multiparametric cytometry data limited the fine characterization of cellular products. To allow the analysis of dynamic and complex flow cytometry samples, we developed cytoChain, a novel dataset mining tool and a new analytical workflow. CytoChain was challenged to compare state-of-the-art and innovative culture conditions to generate stem-like memory cells (TSCM) suitable for ACT. Noticeably, the combination of IL-7/15 and superoxides scavenging sustained the emergence of a previously unidentified nonexhausted Fit-TSCM signature, overlooked by manual gating and endowed with superior expansion potential. CytoChain proficiently traced back this population in independent datasets, and in T-cell receptor engineered lymphocytes. CytoChain flexibility and function were then further validated on a published dataset from circulating T cells in COVID-19 patients. Collectively, our results support the use of cytoChain to identify novel, functionally critical immunophenotypes for ACT and patients immunomonitoring. 相似文献
63.
Liesel M. FitzGerald Xiaotun Zhang Suzanne Kolb Erika M. Kwon Ying Ching Liew Antonio Hurtado‐Coll Beatrice S. Knudsen Elaine A. Ostrander Janet L. Stanford 《Human mutation》2013,34(1):149-156
Two genome‐wide association studies (GWAS) identified the β‐microseminoprotein (MSMB) promoter SNP, rs10993994:C>T, as significantly associated with prostate cancer (PC) risk. Follow‐up studies demonstrate that the variant allele directly affects expression of the MSMB‐encoded protein, PSP94, and also suggest that it affects mRNA expression levels of an adjacent gene, NCOA4, which is involved in androgen receptor transactivation. In a population‐based study of 1,323 cases and 1,268 age‐matched controls, we found the NCOA4 SNP, rs7350420:T>C, was associated with a 15% reduction in PC risk, but the association was not significant after adjustment for the rs10993994:C>T genotype. Tumor tissue microarrays of 519 radical prostatectomy patients were used to measure PSP94 and NCOA4 protein expression. Taken together, these data confirm that the rs10993994:C>T variant allele is associated with decreased PSP94 expression, and the association is stronger in tumor compared to normal prostate tissue. No association was observed between rs10993994:C>T and NCOA4 expression, and only moderate associations were seen between two NCOA4 SNPs, rs10761618:T>C and rs7085433:G>A, and NCOA4 protein expression. These data indicate that the increase in PC risk associated with rs10993994:C>T is likely mediated by the variant's effect on PSP94 expression; however, this effect does not extend to NCOA4 in the data presented here. 相似文献
64.
65.
Impact of recipient ABH secretor status on outcome in minor ABO‐incompatible hematopoietic stem cell transplantation 下载免费PDF全文
66.
Kyle D. Smith Beatrice Achan Kathy Huppler Hullsiek Tami R. McDonald Laura H. Okagaki Ali A. Alhadab Andrew Akampurira Joshua R. Rhein David B. Meya David R. Boulware Kirsten Nielsen 《Antimicrobial agents and chemotherapy》2015,59(12):7197-7204
Cryptococcal antigen screening is recommended among people living with AIDS when entering HIV care with a CD4 count of <100 cells/μl, and preemptive fluconazole monotherapy treatment is recommended for those with subclinical cryptococcal antigenemia. Yet, knowledge is limited of current antimicrobial resistance in Africa. We examined antifungal drug susceptibility in 198 clinical isolates collected from Kampala, Uganda, between 2010 and 2014 using the CLSI broth microdilution assay. In comparison with two previous studies from 1998 to 1999 that reported an MIC50 of 4 μg/ml and an MIC90 of 8 μg/ml prior to widespread human fluconazole and agricultural azole fungicide usage, we report an upward shift in the fluconazole MIC50 to 8 μg/ml and an MIC90 value of 32 μg/ml, with 31% of isolates with a fluconazole MIC of ≥16 μg/ml. We observed an amphotericin B MIC50 of 0.5 μg/ml and an MIC90 of 1 μg/ml, of which 99.5% of isolates (197 of 198 isolates) were still susceptible. No correlation between MIC and clinical outcome was observed in the context of amphotericin B and fluconazole combination induction therapy. We also analyzed Cryptococcus susceptibility to sertraline, with an MIC50 of 4 μg/ml, suggesting that sertraline is a promising oral, low-cost, available, novel medication and a possible alternative to fluconazole. Although the CLSI broth microdilution assay is ideal to standardize results, limit human bias, and increase assay capacity, such assays are often inaccessible in low-income countries. Thus, we also developed and validated an assay that could easily be implemented in a resource-limited setting, with similar susceptibility results (P = 0.52). 相似文献
67.
Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia 下载免费PDF全文
Dana Wetzel Beatrice U. Mueller Behrouz Mansouri Taleghani Gabriela M. Baerlocher Katja Seipel Kurt Leibundgut Thomas Pabst 《British journal of haematology》2015,168(2):268-273
Autologous stem cell transplantation (ASCT) is applied to consolidate first remission in patients with acute myeloid leukaemia (AML). However, outcome after ASCT widely varies among AML patients. We analyzed the prognostic significance of haematological recovery for neutrophils [absolute neutrophil count (ANC) >1·0 × 109/l] and platelets (platelet count >20·0 × 109/l), stratifying at day 20 after ASCT in 88 consecutive and homogeneously treated AML patients in first remission. We observed that patients with delayed recovery had better overall survival (OS; ANC: P < 0·0001 and platelets: P = 0·0062) and time to progression (TTP; ANC: P = 0·0003 and platelets: P = 0·0125). Delayed recovery was an independent marker for better OS and TTP in a multivariate analysis including age, gender, number of transfused CD34+ cells, cytogenetics, FLT3‐internal tandem duplication and NPM1 mutation. Our results suggest that delayed neutrophil and platelet recovery is associated with longer OS and TTP in AML patients consolidated with ASCT in first remission. 相似文献
68.
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma
Vanessa?Desantis Maria?Antonia?Frassanito Roberto?Tamma Ilaria?Saltarella Lucia?Di?Marzo Aurelia?Lamanuzzi Antonio?Giovanni?Solimando Simona?Ruggieri Tiziana?Annese Beatrice?Nico Angelo?Vacca Domenico?RibattiEmail authorView authors OrcID profile 《Annals of hematology》2018,97(7):1251-1258
We have previously demonstrated that recombinant human erythropoietin (rHuEpo) is involved in the regulation of the angiogenic response in multiple myeloma (MM) through a direct effect on macrophages and endothelial cells isolated from the bone marrow of patients with MM. The aim of the present study was designed to determine the effects of rHuEpo on cancer-associated fibroblasts (CAFs) from monoclonal gammopathy of undetermined significance (MGUS) and MM patients by means of in vitro and in vivo assays. rHuEpo treatment reduces the expression of mRNA levels of fibroblast activation markers, namely alpha smooth actin (αSMA) and fibroblast activation protein (FAP) in MGUS and MM CAFs, and of pro-inflammatory and pro-angiogenic cytokines, including interleukin (IL)-6 and IL-8, vascular endothelial growth factor-A (VEGF-A), fibroblast growth factor-2 (FGF-2), and hepatocyte growth factor (HGF) in MM CAFs. Moreover, rHuEpo inhibits the proliferative activity of MM CAFs and increased the apoptosis of MGUS and MM CAFs. Overall, these data suggest that rHu-Epo down-regulates CAFs pro-tumorigenic activity. Moreover, these results are not suggestive for a pro-angiogenic activity of rHuEpo on CAFs. In fact, rHuEpo pre-treatment induces a low angiogenic response in vivo in the chorioallantoic membrane (CAM) assay of MGUS and MM CAFs conditioned medium, not comparable to that of a well-known angiogenic cytokine, VEGF-A, tested in the same assay. 相似文献
69.
Cicoira M Rossi A Bonapace S Zanolla L Golia G Franceschini L Caruso B Marino PN Zardini P 《Journal of cardiac failure》2004,10(5):403-411
BACKGROUND: In chronic heart failure (CHF), changes in the extracellular space contribute to cardiac dysfunction. We aimed to determine whether aminoterminal-propeptide of type III procollagen (PIIINP), a marker of extracellular matrix turnover, might provide prognostic information in CHF patients. METHODS AND RESULTS: A total of 101 consecutive CHF patients (mean age 61.7 +/- 8.7 years, 88% males) were followed up between 1999 and 2001. The combined endpoint of the study was death and hospitalization for heart failure. During follow-up there were 15 deaths and 11 hospitalizations for worsening heart failure. At the survival analysis, age (P = .02), New York Heart Association class (P = .014), s-creatinine (P = .014), plasma-PIIINP (p-PIIINP) levels (P = .005), left ventricular ejection fraction (LVEF) (P = .0002), and a restrictive mitral filling pattern (P = .0003) predicted event-free survival. At the multivariate analysis, p-PIIINP levels predicted outcome independently of other clinical variables, hormones, and echocardiographic and exercise testing variables (P < .05 in all models). In patients with LVEF <31%, the presence of p-PIIINP >4.7 microg/L levels was significantly associated with a higher risk of death and hospitalization as compared with the other patients (event-free survival rate at 12 months: 45% versus 95%; at 24 months: 27% versus 88%; at 36 months: 18% versus 85%, P < .0001). CONCLUSIONS: In patients with CHF, PIIINP levels predict outcome independently of clinical status, hemodynamics and hormonal activation. PIIINP levels provide additional prognostic information to that of left ventricular function alone, suggesting that it may reflect more than cardiac extracellular matrix turnover. 相似文献
70.
Vito Crincoli Mariasevera Di Comite Maria Beatrice Di Bisceglie Laura Fatone Gianfranco Favia 《International journal of medical sciences》2015,12(4):341-348
AIMS: Psoriasis is a chronic, remitting and relapsing inflammatory disorder, involving the skin, nails, scalp and mucous membranes, that impairs patients'' quality of life to varying degrees. Psoriatic arthritis is a chronic seronegative, inflammatory arthritis, usually preceded by psoriasis. Temporomandibular disorders is a generic term referred to clinical conditions involving the jaw muscles and temporomandibular joint. The aim of this study was to assess symptoms and signs of temporomandibular disorders in psoriasis patients with and without psoriatic arthritis.METHODS: The study group included 112 patients (56 men, 56 women; median age 49.7±12 years) with psoriasis, 25 of them were affected by psoriatic arthritis. A group of 112 subjects without psoriasis (56 men, 56 women; median age 47.7±17 years) served as controls. Signs and symptoms of temporomandibular disorders were evaluated according to the standardized Research Diagnostic Criteria for Temporomandibular Disorders. Psoriasis patients were subgrouped according to the presence/absence of psoriatic arthritis and by gender, to assess the prevalence of traditional symptoms and signs of temporomandibular disorders.RESULTS: Patients with psoriasis, and to an even greater extent those with psoriatic arthritis, were more frequently affected by symptoms and signs of temporomandibular disorders, including an internal temporomandibular joint opening derangement than healthy subjects. A statistically significant increase in symptoms of temporomandibular disorders, in opening derangement, bruxism and sounds of temporomandibular joint was found in patients with psoriatic arthritis as compared with psoriasis patients without arthritis and controls.CONCLUSIONS: psoriasis seems to play a role in temporomandibular joint disorders, causing an increase in orofacial pain and an altered chewing function. 相似文献